Search filters

List of works by Niranjan Awasthi

A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis

scientific article published on 22 February 2019

A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma

scientific article

An antiendothelial combination therapy strategy to increase survival in experimental pancreatic cancer

scientific article

Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation.

scientific article published on 20 April 2010

Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer ⬇️

scientific article published on June 7, 2011

Augmentation of Nab-Paclitaxel Chemotherapy Response by Mechanistically Diverse Antiangiogenic Agents in Preclinical Gastric Cancer Models

scientific article published on 30 August 2018

Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models

scientific article published on 26 April 2016

BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer ⬇️

scientific article published on October 9, 2012

CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer

scientific article

Cell proliferation and migration are modulated by Cdk-1-phosphorylated endothelial-monocyte activating polypeptide II

scientific article

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma

scientific article published on 26 November 2019

Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer

scientific article published on 26 July 2010

Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer

scientific article

Downregulation of MMP-2 and -9 by proteasome inhibition: a possible mechanism to decrease LEC migration and prevent posterior capsular opacification

scientific article published on May 2008

Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancer

scientific article published on 30 May 2019

EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer

scientific article published on 30 December 2009

Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity

scientific article published on 2 June 2016

Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling

scientific article published on 10 November 2008

Enhancement of nab-paclitaxel antitumor activity through addition of multitargeting antiangiogenic agents in experimental pancreatic cancer.

scientific article published on 7 March 2014

Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy ⬇️

scientific article published on November 26, 2010

Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II.

scientific article published on 6 March 2013

Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer

scientific article published on 15 November 2012

Evaluation of Poly-Mechanistic Antiangiogenic Combinations to Enhance Cytotoxic Therapy Response in Pancreatic Cancer ⬇️

scientific article published on June 18, 2012

Immunoproteasome expression in a nonimmune tissue, the ocular lens

scientific article published on September 2002

Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer

scientific article published on 25 December 2017

Interferon-gamma induces apoptosis of lens alphaTN4-1 cells and proteasome inhibition has an antiapoptotic effect

scientific article published on January 2004

Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer.

scientific article published on 16 December 2014

PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancer.

scientific article published on 21 May 2013

Pancreatic ductal adenocarcinoma cell secreted extracellular vesicles containing ceramide-1-phosphate promote pancreatic cancer stem cell motility

scientific article published on 15 September 2018

Posterior capsular opacification: a problem reduced but not yet eradicated

scientific article

Profile of nintedanib in the treatment of solid tumors: the evidence to date

scientific article

Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer

scientific article

Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer ⬇️

scientific article published on January 12, 2011

Specific activation of the glucocorticoid receptor and modulation of signal transduction pathways in human lens epithelial cells

scientific article

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma.

scientific article published on 20 February 2018

Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer

scientific article

Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification

scientific article

The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein

scientific article

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer

scientific article

The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer

scientific article

Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer.

scientific article published on 2 April 2019

Upregulation of heat shock protein expression by proteasome inhibition: an antiapoptotic mechanism in the lens

scientific article published in June 2005

Paulina is supported by:

About Paulina

Help